Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q2 2017 Earnings

9MayConfirmed

Q3 2016

Q4 2016

Q1 2017

Q2 2017

-0.28

-0.26

-0.23

-0.21

Details

Expected EPS

-0.24

Actual EPS

-0.26

Surprise EPS

-0.02

Surprise Percent

+8.33%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.26 per share for Q2 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.